Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,580 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 533 · Balance 15,580 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 834 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 530 · Balance 834 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,023 |
Reported balance
After 2026-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-10 · Grant · Acquired 189 · Balance 1,023 F2: On June 10, 2026, the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. |
| Common StockSEC Table I · non-derivative | Indirectthe James W. Quinn 2025 GRAT No.1 | 36,223 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 36,223 |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends.
F2: On June 10, 2026, the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2023 Filed Jun 21, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001415889-23-010096 · form4-06212023_040601.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 5,000 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2023 Filed Jun 21, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,000 | $26.88 | $134,400.00 |
DisclosureSEC source: 0001415889-23-010096 · form4-06212023_040601.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 21, 2023 the Reporting Person exercised the remainder of his stock option received on December 17, 2013 and purchased 5,000 shares of the Issuer's common stock at a price of $26.88 per share. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001415889-23-004489 · form4-03082023_040304.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 5,000 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,000 | $26.88 | $134,400.00 |
DisclosureSEC source: 0001415889-23-004489 · form4-03082023_040304.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 7, 2023 the Reporting Person exercised a portion of his stock option received on December 17, 2013 and purchased 5,000 shares of the Issuer's common stock at a price of $26.88 per share. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012847 · form4-12202022_041212.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of their grant date on 12/16/2025. F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012847 · form4-12202022_041212.xml · derivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006025 · form4-12162021_041206.xml · derivative · entry 3 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F5 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of their grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006025 · form4-12162021_041206.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and F4 · balance_after: (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:19 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136301 · tm2038593d5_4seq1.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 of the Issuer's Common Stock at an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; F3 · balance_after: (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:47 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001104659-19-076014 · a4.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; F3 · balance_after: (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; and (g) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning 12/23/2020 and Expiration Date of 12/23/2029. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:19 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 5,000 | $35.92 | $179,600.00 |
DisclosureSEC source: 0001104659-19-073479 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,570 Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 21:40 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001104659-18-002082 · a4.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $ 26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:19 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $18.87 | $0.00 |
DisclosureSEC source: 0001104659-17-072735 · a4.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.underlying_shares: On December 8, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $ 26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:19 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $18.87 | $188,700.00 |
DisclosureSEC source: 0001104659-17-072735 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 8, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 01:33 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 6,826 | $66.24 | $452,159.70 |
DisclosureSEC source: 0001104659-17-024999 · a4.xml · nonDerivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,570 F2 · shares: On April 20, 2017, the Reporting Person sold 6,826 shares of the Issuer's common stock on the open market at an average price of $66.2408 per share. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 01:33 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 3,174 | $66.00 | $209,498.92 |
DisclosureSEC source: 0001104659-17-024999 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,396 F1 · shares: On April 19, 2017, the Reporting Person sold 3,174 shares of the Issuer's common stock on the open market at an average price of $66.0047 per share. Read SEC document |
| January 05, 2017 Filed Feb 24, 2017 22:01 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $71.75 | $0.00 |
DisclosureSEC source: 0001104659-17-011625 · a4.xml · derivative · entry 2 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 F1 · shares: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (b) options to acquire 10,000 shares of common stock at a price of $ 26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (c) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (d) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017and Expiration Date of 1/7/2026; and (e) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:23 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $70.78 | $707,751.00 |
DisclosureSEC source: 0001104659-17-000582 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,570 F1 · shares: On January 3, 2017, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's common stock on the open market at an average price of $70.7751 per share. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:55 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $58.86 | $588,589.00 |
DisclosureSEC source: 0001104659-16-148631 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,570 F1 · shares: On October 3, 2016, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's common stock on the open market at a price of $58.8589 per share. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:04 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $57.08 | $570,848.00 |
DisclosureSEC source: 0001104659-16-146811 · a4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,570 F1 · shares: On September 23, 2016, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's common stock on the open market at a price of $57.0848 per share. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 20:43 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $56.41 | $564,116.00 |
DisclosureSEC source: 0000899243-16-029598 · doc4.xml · nonDerivative · entry 1 QUINN JAMES W · CIK 0001094454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,570 F1 · shares: On September 19, 2016, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's common stock on the open market at a price of $56.4116 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.